DDX5 and Alzheimer disease: This study found that DDX5 significantly decreases in AD, and the downregulation of DDX5 may inhibit various biological functions, such as ATP binding, hydrolysis, RNA binding and unwinding, transcription, splicing, and cell proliferation and differentiation, which may be the underlying pathological aspects of AD.